Scientists map dendritic cell reactions to vaccines 

Ghent, 26 August 2025 – Belgian scientists have uncovered new details about how the immune system responds to vaccines. Dendritic cells, which are key immune messengers that help kick-start the body’s defenses, show specific responses to lipid nanoparticles. These findings, published in Cell Reports, could lead to safer and more effective vaccines. ​ 

Dendritic cells and lipid nanoparticles 

Dendritic cells are among the first to detect viruses, bacteria, or other immune challenges. These cells help coordinate the immune system’s response by alerting T cells, the immune system’s soldiers trained to eliminate threats. But dendritic cells don't always respond in the same way. Some keep the immune system calm and balanced (homeostatic), while others drive a full immune attack (immunogenic). 

Until now, little was known about what determines these different responses, especially when dendritic cells encounter vaccines. 

The team of Prof. Sophie Janssens (VIB-UGent Center for Inflammation), and colleagues at the University of Ghent, the VIB Single Cell Core, and the University of Brussels, investigated how dendritic cells react to lipid nanoparticles (LNPs), the technology used in mRNA vaccines. LNPs are tiny spheres that deliver genetic instructions to immune cells, prompting them to produce virus-fighting proteins. 

Prof. Sophie Janssens
Prof. Sophie Janssens

Calm or activated?  

Using cutting-edge methods like CITE-sequencing and flow cytometry, the researchers discovered that LNPs can influence dendritic cells to adopt either a calm, homeostatic role or an activated, immunogenic one. 

“We found that empty LNPs don’t strongly activate the immune system,” said Dr. Sofie Rennen (VIB-UGent), first author of the study. “That’s good news, because it means they can deliver vaccine components without triggering unintended inflammation. But more importantly, by choosing what we load into them, we can steer the immune response in specific ways.” 

For example, LNPs carrying antigens encoded as mRNA molecules prompted dendritic cells to take on an immunogenic role: activating T cells and driving protection. In contrast, empty LNPs or LNPs carrying peptides supported a more homeostatic profile, potentially useful for promoting immune tolerance. 

Dr. Victor Bosteels (VIB-UGent), co-first author, adds, “Our work might lay the groundwork for 'calming’ vaccines for autoimmune diseases by encouraging a healthy immune system instead of inflammation.” 
“Overall,” says Prof. Janssens (VIB-UGent), “mapping how dendritic cells respond to different vaccine elements allows us to target the immune system more precisely and safely, which can lead to the next generation of vaccines.” 

Publication 

Lipid nanoparticles as a tool to dissect dendritic cell maturation pathways. Rennen, Bosteels, et al. Cell Reports, 2025. 

Funding 

This work was supported by ERC, FWO, and Ghent University. 


Gunnar De Winter

Gunnar De Winter

Science Communication Manager, VIB

Share

Latest stories

Researchers discover clues for Alzheimer’s disease in hibernation

Researchers discover clues for Alzheimer’s disease in hibernation

Leuven, 12 November 2026 – Researchers at VIB and KU Leuven have discovered that hibernation triggers changes in brain cells that partially resemble those in Alzheimer’s disease. Studying golden hamsters, the team identified changes in gene expression across the hibernation cycle, which resemble those associated with the accumulation of amyloid plaques in Alzheimer’s. The findings, published in Science Advances, suggest that some early cellular changes associated with Alzheimer’s may also occur as part of a natural adaptive response, offering new ways to study the disease for therapy development.

press.vib.be

An inside look at a molecular switch that triggers inflammation

An inside look at a molecular switch that triggers inflammation

Ghent, 9 November 2026 – Researchers at VIB and Ghent University have uncovered how an important driver of inflammation is activated at the molecular level. Their findings, published in Science Immunology, also explain how a medicine used to treat a severe form of psoriasis blocks this inflammatory signal.

press.vib.be

Researchers uncover why humans are more sensitive than other species to a brain developmental disease

Researchers uncover why humans are more sensitive than other species to a brain developmental disease

Leuven, 4 November 2026 – Researchers at VIB and KU Leuven have uncovered how mutations in the ASPM gene disrupt the development of neural stem cells that help the human brain grow. This disruption explains how these mutations cause microcephaly, a condition characterized by an abnormally small brain and head, often accompanied by intellectual disability. The discovery, published in Developmental Cell, also sheds light on how differences in brain development can make humans more susceptible to certain genetic conditions than other mammals.

press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be